Public Confidence in Vaccines Sags, New Report Finds.
According to a survey released Monday by the American Society for Microbiology and Research in America, the percentage of American adults who say it’s “very important” to have their children vaccinated was down 11 points over the past decade, at 71 percent in May from 82 percent in 2008. The percentage that expressed confidence in the system for evaluating the safety of vaccines to determinate their proper use dropped 8 percentage points, from 85 percent in 2008 to 77 percent in May. Likewise, the survey found that the percentage of Americans who strongly believe they have benefited from the development of vaccines over the past 50 years has dropped from 75 percent a decade ago to 59 percent this month. US News and World Report May 21, 2018.
TO TRACK VACCINE COMPLIANCE
(Natural News) The Centers for Disease Control (CDC) is essentially the vaccine compliance and enforcement division of the pharmaceutical industry. Their newly developed program, Immunization Information Systems (IIS), is part of the roll out of a kind of “medical police state” which would allow the government to monitor and track the mandatory vaccine compliance of every citizen.
This data is collected automatically; there is no consent. The database tracks your personal and family health decisions, even when you say NO to a vaccine. The database will identify areas of “under vaccination” and track citizens who are not in compliance with the current childhood and adult vaccine schedules. Continue reading
Some lies are so big, many people can’t accept the fact that they’re lies. Their minds are boggled. “No,” they say, “that couldn’t be.” But yes, that could be, and is.
Two giant vaccine scandals are in progress at the moment.
The mainstream press is mentioning them, here and there, but without any intent to raise alarms, dig in, investigate, and get down to the core of the problem.
So I’ll get to the core.
The first scandal revolves around the flu vaccine for the current year. The CDC and other “experts” have admitted the vaccine has a very low effectiveness rate.
Why is it a dud?
Because the vaccine is produced using chicken eggs, and in that medium, the flu virus—which is intentionally placed in the eggs—mutates. Therefore, it isn’t the same virus which is causing flu this year. Therefore, no protection against the flu.
FiercePharma reports: “Based on data from Australia, which already had its flu season, scientists warn that this season’s flu shot might be only 10% effective. And the reason for such a low level of protection might lie in the method by which the majority of flu vaccines are made: in eggs.”
Ten percent effectiveness. Now that’s ridiculous. And it’s assuming you accept the whole model of how vaccines work—that they actually do protect (safely) against disease, rather than, at best, repressing the visible symptoms of the disease.
Amidst their spotty coverage of this scandal, here is what the press is failing to mention: the problem with the flu vaccine isn’t just a 2017-2018 flaw.
It would be the same problem ever since chicken eggs have been used to manufacture the vaccine.
Are you ready?
Healthline.com: “The majority of flu vaccines are grown in chicken eggs, a method of vaccine development that’s been used for 70 years.”
Hello? Anyone home?
Seventy years. The same problem.
The same “low effectiveness” problem.
That’s a page-one story with a giant headline. That’s the lead item on the nightly news. That’s a pounding investigative series about the lunatic promotion of a massively ineffective—but universally promoted—vaccine going back decades and decades.
But it isn’t a giant headline. It isn’t an investigation. It’s a here-today-gone-tomorrow piece. That’s all.
The second scandal keeps unfolding in the Philippines, where drug giant Sanofi’s Dengvaxia, given to prevent Dengue Fever, is facing enormous pushback from government officials, who stopped the national vaccination campaign, after thousands of children already received the shot.
The issue? Safety.
FiercePharma: “The Philippines stopped vaccinations shortly after the company warned that Dengvaxia can cause more serious infections in those who previously hadn’t had exposure to the virus. The country also kicked off a probe and plans legal action, according to health secretary Francisco Duque.”
Did you get that? The company (Sanofi) itself warned that vaccine might not be safe.
FiercePharma: “…the [Philippine] Department of Health didn’t heed warnings from an advisory group of doctors and pharmacologists, who concluded early last year that the vaccine’s safety and efficacy were unproven.”
But let’s dig even deeper. Sanofi saying is saying the vaccine might be dangerous for those who haven’t been exposed to the Dengue virus before getting the shot. What on Earth does that mean?
It means a child who had naturally come in contact with the virus would have developed his own antibodies to it. And later, those antibodies would protect him against the Dengue virus IN THE VACCINE. Otherwise, the virus in the vaccine could give him a case of Dengue or cause some other form of damage.
This is saying, “If a child is ALREADY immune to Dengue Fever, because his immune system has successfully dealt with the virus, then the vaccine won’t damage him.”
And THAT is saying, “If the child has naturally developed an immunity to Dengue, then the vaccine, WHICH HE DOESN’T NEED, won’t harm him.”
Of course, the press isn’t getting the picture. If any reporters are seeing the light, they’re keeping their mouths shut. The scandal is too big and too crazy.
Between the lines, a vaccine company is admitting their vaccine is only safe for children who don’t need it.
A tree just fell in the forest. Who heard it?
It is no secret that huge conflicts of interest exist between vaccine promoters and vaccine makers. Pediatrician and vaccine developer Paul Offit, for example, who is one of the nation’s leading promoters of mandatory use of government recommended vaccines, holds a $1.5 million research chair at Children’s Hospital in Philadelphia, funded in part by Merck.1 Julie Gerberding left her post as Director of the Centers for Disease Control and Prevention (CDC), where she oversaw the creation of national vaccine policies, to head Merck vaccines.2 Former Texas governor Rick Perry recommended state-wide inoculation of all 11- and 12-year-old girls with Merck’s Gardasil vaccine after his chief of staff left to work at Merck.3 4
Just as disturbing are the millions of dollars that officials at the National Institutes of Health (NIH) dole out to academic institutions and vaccine manufacturers to improve vaccine technology, find new, lucrative markets and boost vaccine marketability—functions that guarantee the profitability of corporations, but do not always ensure the well being of taxpayers, the public and patients.
Once upon a time, before passage of the Bayh-Dole Act by Congress in 1980 and the push for lucrative “technology transfer” business arrangements between federal agencies and for-profit corporations, inventions developed with federal funding were owned by the U.S. Government and not industry. Today, taxpayer-supported research to develop new drugs and vaccines is voraciously patented by universities and drug companies for outsized Wall Street profits when the research rightfully belongs to taxpayers.5
Development of the human papillomavirus (HPV) Gardasil and Cervarix vaccines is a case in point. The initial research was funded by the NIH, National Cancer Institute, University of Rochester, Georgetown University and the University of Queensland, which licensed them to Merck and GlaxoSmithKline.6 7 In 2015, Merck made $1.9 billion on its Gardasil franchise.8
Soon, aggressive domestic and overseas marketing of the expensive HPV vaccines began, even as the vaccines themselves got poor marks for both safety and effectiveness. In 2006, consumer advocacy groups had protested the FDA’s fast tracking of Gardasil vaccine to licensure, citing inadequate safety data.9 Reports of sudden collapse/fainting (syncope) and serious neurological and immune system problems after Gardasil vaccinations emerged immediately after the vaccine was licensed.10